Skip to content
healthcare.dev

KLOR-CON M

NDC 0245-5319, potassium chloride, tablet, extended release, from Upsher-Smith Laboratories, LLC.

Product NDC
0245-5319
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074726
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0245-5319 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CHLORIDE1500 mg/1

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
0245-5319-0100245531901100 BLISTER PACK in 1 CARTON (0245-5319-01) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0245-5319-89)
0245-5319-10002455319101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-10)
0245-5319-1100245531911100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-11)
0245-5319-1500245531915500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-15)
0245-5319-900024553199090 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b89910f6-4ff5-4a62-8269-696f7c10e4f6
  • NADAC price for package 00245531901

    GET /v1/drugs/nadac/00245531901
  • NADAC price for package 00245531910

    GET /v1/drugs/nadac/00245531910
  • NADAC price for package 00245531911

    GET /v1/drugs/nadac/00245531911
  • NADAC price for package 00245531915

    GET /v1/drugs/nadac/00245531915
  • NADAC price for package 00245531990

    GET /v1/drugs/nadac/00245531990

Use it

Look up 0245-5319 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0245-5319 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0245-5319. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.